David Altshuler has been appointed to the board of directors at Vertex Pharmaceuticals. He is a professor of genetics and medicine at Harvard Medical School, where he has served on the faculty since 2000. He is also a founding member of the Broad Institute and on the faculty of Massachusetts General Hospital in its Department of Molecular Biology, the Diabetes Unit of the Department of Medicine, and in the Center for Human Genetic Research.